BioCentury
ARTICLE | Company News

Eli Lilly, Transition Therapeutics deal

May 18, 2015 7:00 AM UTC

Eli Lilly granted Transition’s Transition Therapeutics Ireland Ltd. subsidiary exclusive, worldwide rights to develop and commercialize TT701. Transition is evaluating multiple indications for the pr...